New clinical trial achieves reversal of cognitive decline

For over a decade Dr Bredesen has been pioneering a new form of treatment for Alzheimer’s disease and other forms of cognitive decline, and this clinical trial is the most recent of a number of trials demonstrating the efficacy of this approach.

On 14 July 2023 Dr Heather Sandison joined Dr Bredesen and Dr Rao to discuss her peer-reviewed paper, co-authored by Dr Rao, that demonstrated cognitive improvement through the clinical application of the Bredesen Protocol®. These results build on Dr Bredesen’s earlier clinical trial showing improvement or stabilisation in more than 84% of participants.

Watch the webinar now to learn:

  • How the Bredesen Protocol was implemented using multimodal, individualised care plans that addressed personalised contributors to cognitive decline (e.g. nutritional status, infection, etc.).

  • How the intervention improved MoCA scores, CBS memory domain, and CBS overall composite cognition scores.

  • How you could benefit from following the Bredesen Protocol.

WATCH HERE